Heart failure support for people with methamphetamine use
Part of Heart & circulation clinical trials.
This study tests a support program for people with heart failure who also use methamphetamine and want to quit. It aims to improve both heart health and recovery from substance use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with heart failure and your heart's pumping strength is 40% or less.
- You currently use methamphetamine and want to stop using it.
- You are at least 18 years old.
- You are a patient at LA General Medical Center/DHS.
- You can understand the study and give your permission (consent).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a peer support program can help people who use methamphetamine get screened for early heart damage. It aims to connect you with care if screening shows possible heart strain.
This study tests whether people who use methamphetamine can reduce use even if they are not completely abstinent. It offers a 12-week program and checks how you're doing for another 12 weeks after.
This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.
This study tests a program that uses rewards (like gift cards) to encourage people who use methamphetamine and have been hospitalized for a trauma to stop using. The program is designed for people in Hawaii and aims to help them reduce or quit methamphetamine use.
This study tests whether starting a reward-based treatment program while you are still in the hospital can help reduce methamphetamine use after a traumatic injury. You may be able to join if you test positive for methamphetamine, use it at least weekly, and have moderate or severe trouble controlling your use.
This study tests whether a high dose of a stimulant medication (lisdexamfetamine, an ADHD medicine) taken over many weeks can help people who have already completed a methamphetamine treatment program to stay off meth, reduce use, or avoid relapse.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.